EX-10.2
from 10-Q
89 pages
Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Would Likely Cause Competitive Harm to the Company if Publicly Disclosed Credit Agreement Dated as of August 3, 2026 Among Verrica Pharmaceuticals Inc., as Borrower, and Pd Joint Holdings, LLC Series 2016-B, as Lender,
12/34/56
EX-10.1
from 10-Q
101 pages
Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Omissions Are Designated [***]. Credit Agreement Dated as of July 26, 2023 Among Verrica Pharmaceuticals Inc., as the Borrower, Orbimed Royalty & Credit Opportunities IV, LP, as the Initial Lender and Administrative Agent
12/34/56